Table 3.
Associations between clinical and technical outcomes and the use of a (non-)BGC
| BGC with inflated balloon as first modality | EE | BGC without inflated balloon | Non-BGC | ||
|---|---|---|---|---|---|
| Unadjusted | Adjusted | Unadjusted | Adjusted | ||
| mRS at 90 days* | cOR |
1.25 (0.82–1.92) |
1.07 (0.67–1.73) |
1.40 (0.86–2.27) |
1.42 (0.83–2.42) |
| mRS 0–1 at 90 days | OR |
1.32 (0.68–2.58) |
1.00 (0.44–2.24) |
1.53 (0.73–3.21) |
1.32 (0.53–3.24) |
| mRS 0–2 at 90 days | OR |
1.06 (0.64–1.76) |
0.80 (0.41–1.58) |
1.41 (0.81–2.47) |
1.53 (0.72–3.21) |
| Post eTICI score | cOR |
0.57 (0.36–0.90) |
0.59 (0.37–0.94) |
0.77 (0.46–1.28) |
0.79 (0.47–1.35) |
| Successful reperfusion (eTICI ≥ 2B) | OR |
0.85 (0.37–1.91) |
0.89 (0.38–2.10) |
0.80 (0.33–1.96) |
0.85 (0.33–2.23) |
| Excellent reperfusion (eTICI ≥ 2C) | OR |
0.88 (0.52–1.50) |
0.91 (0.52–1.60) |
0.91 (0.52–1.60) |
1.06 (0.56–2.01) |
| Complete reperfusion (eTICI = 3) | OR |
0.41 (0.25–0.67) |
0.43 (0.26–0.73) |
0.67 (0.39–1.16) |
0.70 (0.40–1.24) |
| Mortality at 90 days | OR |
0.74 (0.44–1.25) |
0.93 (0.50–1.74) |
0.78 (0.44–1.40) |
0.77 (0.38–1.56) |
| NIHSS post intervention | % |
0.6 (− 22–30) |
5.4 (− 16–32) |
− 11.8 (− 34–17) |
− 9.8 (30–16) |
| NIHSS ≥ 4 improvement | OR |
0.95 (0.58–1.55) |
0.97 (0.58–1.62) |
1.22 (0.70–2.14) |
1.28 (0.71–2.30) |
| Procedure time | % |
− 2.7 (− 18–16) |
− 8.1 (− 23–9.4) |
− 6.0 (− 23–14) |
− 12 (− 28–7.0) |
| Total attempts | ß |
− 0.15 (− 0.54–0.24) |
− 0.11 (− 0.50–0.29) |
0.24 (− 0.19 − 0.67) |
0.28 (− 0.17–0.72) |
| First-attempt successful (2C-3) | OR |
0.81 (0.50–1.31) |
0.86 (0.52–1.42) |
0.60 (0.35–1.04) |
0.64 (0.36–1.12) |
| Periprocedural complications | OR |
0.82 (0.47–1.43) |
0.70 (0.39–1.27) |
0.47 (0.23–0.94) |
0.41 (0.20–0.86) |
*Common odds ratio for improved mRS score
EE effect estimate, cOR common odds ratio, OR odds ratio, BGC balloon guide catheter, mRS modified Rankin scale, eTICI expanded treatment in cerebral ischemia, NIHSS National Institutes of Health Stroke Scale